These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 21894226)

  • 1. Once-daily dosing vs. conventional dosing schedule of mesalamine and relapse of quiescent ulcerative colitis: systematic review and meta-analysis.
    Ford AC; Khan KJ; Sandborn WJ; Kane SV; Moayyedi P
    Am J Gastroenterol; 2011 Dec; 106(12):2070-7; quiz 2078. PubMed ID: 21894226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
    Murray A; Nguyen TM; Parker CE; Feagan BG; MacDonald JK
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD000544. PubMed ID: 32856298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000544. PubMed ID: 23076890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.
    Wang Y; Parker CE; Feagan BG; MacDonald JK
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD000544. PubMed ID: 27158764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis.
    Ford AC; Achkar JP; Khan KJ; Kane SV; Talley NJ; Marshall JK; Moayyedi P
    Am J Gastroenterol; 2011 Apr; 106(4):601-16. PubMed ID: 21407188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Wang Y; Parker CE; Bhanji T; Feagan BG; MacDonald JK
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD000543. PubMed ID: 27101467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-daily versus multiple-daily mesalamine for patients with ulcerative colitis: a meta-analysis.
    Tong JL; Huang ML; Xu XT; Qiao YQ; Ran ZH
    J Dig Dis; 2012 Apr; 13(4):200-7. PubMed ID: 22435504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of topical 5-aminosalicylates in preventing relapse of quiescent ulcerative colitis: a meta-analysis.
    Ford AC; Khan KJ; Sandborn WJ; Hanauer SB; Moayyedi P
    Clin Gastroenterol Hepatol; 2012 May; 10(5):513-9. PubMed ID: 22083024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of oral vs. topical, or combined oral and topical 5-aminosalicylates, in Ulcerative Colitis: systematic review and meta-analysis.
    Ford AC; Khan KJ; Achkar JP; Moayyedi P
    Am J Gastroenterol; 2012 Feb; 107(2):167-76; author reply 177. PubMed ID: 22108446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once daily vs multiple daily mesalamine therapy for mild to moderate ulcerative colitis: a meta-analysis.
    Li W; Zhang ZM; Jiang XL
    Colorectal Dis; 2016 Jul; 18(7):O214-23. PubMed ID: 27214762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.
    Dignass AU; Bokemeyer B; Adamek H; Mross M; Vinter-Jensen L; Börner N; Silvennoinen J; Tan G; Pool MO; Stijnen T; Dietel P; Klugmann T; Vermeire S; Bhatt A; Veerman H
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):762-9. PubMed ID: 19375519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once daily oral mesalamine compared to conventional dosing for induction and maintenance of remission in ulcerative colitis: a systematic review and meta-analysis.
    Feagan BG; MacDonald JK
    Inflamm Bowel Dis; 2012 Sep; 18(9):1785-94. PubMed ID: 22644954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can oral 5-aminosalicylic acid be administered once daily in the treatment of mild-to-moderate ulcerative colitis? A meta-analysis of randomized-controlled trials.
    Zhu Y; Tang RK; Zhao P; Zhu SS; Li YG; Li JB
    Eur J Gastroenterol Hepatol; 2012 May; 24(5):487-94. PubMed ID: 22465970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis.
    Sandborn WJ; Korzenik J; Lashner B; Leighton JA; Mahadevan U; Marion JF; Safdi M; Sninsky CA; Patel RM; Friedenberg KA; Dunnmon P; Ramsey D; Kane S
    Gastroenterology; 2010 Apr; 138(4):1286-96, 1296.e1-3. PubMed ID: 20064514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of once daily versus twice daily mesalazine for mild-to-moderate ulcerative colitis: A meta-analysis of randomized controlled trials.
    Zheng X; Zhang Z; Wang B; Li J; Qiu C; Zhang Q; Wang X
    Medicine (Baltimore); 2019 Apr; 98(14):e15113. PubMed ID: 30946380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis.
    Ford AC; Kane SV; Khan KJ; Achkar JP; Talley NJ; Marshall JK; Moayyedi P
    Am J Gastroenterol; 2011 Apr; 106(4):617-29. PubMed ID: 21407190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-daily MMX(®) mesalamine for endoscopic maintenance of remission of ulcerative colitis.
    D'Haens G; Sandborn WJ; Barrett K; Hodgson I; Streck P
    Am J Gastroenterol; 2012 Jul; 107(7):1064-77. PubMed ID: 22565161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot feasibility study of once daily versus conventional dosing mesalamine for maintenance of ulcerative colitis.
    Kane S; Huo D; Magnanti K
    Clin Gastroenterol Hepatol; 2003 May; 1(3):170-3. PubMed ID: 15017487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does treatment schedule matter? Once daily versus divided doses of 5-ASAs.
    Kane S
    Dig Dis; 2010; 28(3):478-82. PubMed ID: 20926875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.